Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Calcium signaling pathway 💬
4件: EGFR, ERBB2, FLT4, KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
2 Calcium signaling pathway 💬
8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib 5件: 51, 85, 89, 227, 228 💬
3 Calcium signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
4 Calcium signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
5 Calcium signaling pathway 💬
6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
6 Calcium signaling pathway 💬
4件: FLT4, KDR, PDGFRB, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
7 Calcium signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
8 EGFR tyrosine kinase inhibitor resistance 💬
3件: AXL, KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
9 EGFR tyrosine kinase inhibitor resistance 💬
4件: BRAF, KDR, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
10 EGFR tyrosine kinase inhibitor resistance 💬
3件: EGFR, ERBB2, KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
11 EGFR tyrosine kinase inhibitor resistance 💬
5件: FGFR2, FGFR3, KDR, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib 5件: 51, 85, 89, 227, 228 💬
12 EGFR tyrosine kinase inhibitor resistance 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
13 EGFR tyrosine kinase inhibitor resistance 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
14 EGFR tyrosine kinase inhibitor resistance 💬
3件: KDR, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
15 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
16 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
17 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
18 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Nintedanib 💬 Nintedanib 5件: 51, 85, 89, 227, 228 💬
19 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
20 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
21 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
22 Focal adhesion 💬
5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
23 Focal adhesion 💬
4件: EGFR, ERBB2, FLT4, KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
24 Focal adhesion 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
25 Focal adhesion 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
26 Focal adhesion 💬
5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib 5件: 51, 85, 89, 227, 228 💬
27 Focal adhesion 💬
5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
28 Focal adhesion 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
29 MAPK signaling pathway 💬
7件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
30 MAPK signaling pathway 💬
8件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
31 MAPK signaling pathway 💬
4件: EGFR, ERBB2, FLT4, KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
32 MAPK signaling pathway 💬
8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib 5件: 51, 85, 89, 227, 228 💬
33 MAPK signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
34 MAPK signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
35 MAPK signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
36 PI3K-Akt signaling pathway 💬
8件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
37 PI3K-Akt signaling pathway 💬
4件: EGFR, ERBB2, FLT4, KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
38 PI3K-Akt signaling pathway 💬
8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib 5件: 51, 85, 89, 227, 228 💬
39 PI3K-Akt signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
40 PI3K-Akt signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
41 PI3K-Akt signaling pathway 💬
6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
42 PI3K-Akt signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
43 Proteoglycans in cancer 💬
3件: BRAF, KDR, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
44 Proteoglycans in cancer 💬
3件: EGFR, ERBB2, KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
45 Proteoglycans in cancer 💬
2件: FGFR1, KDR 💬 Nintedanib 💬 Nintedanib 5件: 51, 85, 89, 227, 228 💬
46 Proteoglycans in cancer 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
47 Proteoglycans in cancer 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
48 Proteoglycans in cancer 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
49 Proteoglycans in cancer 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
50 Rap1 signaling pathway 💬
6件: BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
51 Rap1 signaling pathway 💬
7件: CSF1R, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
52 Rap1 signaling pathway 💬
3件: EGFR, FLT4, KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
53 Rap1 signaling pathway 💬
8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib 5件: 51, 85, 89, 227, 228 💬
54 Rap1 signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
55 Rap1 signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
56 Rap1 signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
57 Ras signaling pathway 💬
8件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
58 Ras signaling pathway 💬
3件: EGFR, FLT4, KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
59 Ras signaling pathway 💬
8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib 5件: 51, 85, 89, 227, 228 💬
60 Ras signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
61 Ras signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
62 Ras signaling pathway 💬
6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
63 Ras signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
64 VEGF signaling pathway 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
65 VEGF signaling pathway 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
66 VEGF signaling pathway 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
67 VEGF signaling pathway 💬
1件: KDR 💬 Nintedanib 💬 Nintedanib 5件: 51, 85, 89, 227, 228 💬
68 VEGF signaling pathway 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
69 VEGF signaling pathway 💬
1件: KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
70 VEGF signaling pathway 💬
2件: KDR, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬